| For: | Chisthi MM. Current research status and future directions of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(3): 99068 [PMID: 40092943 DOI: 10.4251/wjgo.v17.i3.99068] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v17/i3/99068.htm |
| Number | Citing Articles |
| 1 |
Zizhuo Wang, Wei Xu, Songlin Song, Yanqiao Ren, Jiacheng Liu, Yiming Liu, Xuefeng Kan, Chuansheng Zheng, Bin Liang. Efficacy and Safety of HAIC Combined with PD-(L)1 Inhibitors and Bevacizumab Versus HAIC with PD-(L)1 Inhibitors and TKIs in Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study. Cancers 2026; 18(2): 314 doi: 10.3390/cancers18020314
|
| 2 |
Li Gao, Hong Wu, Sheng-Yuan Du, Zi-Li Lv. Therapeutic potential of CDK8 inhibitor combined with sorafenib for hepatocellular carcinoma: mechanistic insights and in vitro validation. European Journal of Medical Research 2026; 31(1) doi: 10.1186/s40001-025-03780-0
|
| 3 |
Yili Qu, Haizhi Xu, Xianjun Guo, Chunyan Zhang, Bei Xu. Effectiveness of a nurse-led pain management model following TACE: a retrospective analysis. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-09399-9
|
